Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis

• Bruce E StroberYale University
• Laura C. CoatesUniversity of Oxford
• Mark LebwohlIcahn School of Medicine at Mount Sinai
• Atul A. DeodharOregon Health & Science University
• Evan LeibowitzJanssen Scientific Affairs (United States)
• Katelyn RowlandJanssen Scientific Affairs (United States)
• Alexa P. Kollmeier
• Megan Jo Miller
• Yanli Wang
• Shu Li
• Soumya D. ChakravartyJanssen Scientific Affairs (United States)
• Daphne ChanJanssen Scientific Affairs (United States)
• May ShawiJanssen Research & Development (United States)
• Ya‐Wen YangJohnson & Johnson (United States)
• Diamant ThaҫiUniversity of Lübeck
• Proton RahmanMemorial University of Newfoundland